{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:30:54Z","timestamp":1787679054485,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872522, 82073429"],"award-info":[{"award-number":["81872522, 82073429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12015-023-10556-8","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:03:10Z","timestamp":1684396990000},"page":"1922-1936","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparative Analysis of the Therapeutic Effects of Fresh and Cryopreserved Human Umbilical Cord Derived Mesenchymal Stem Cells in the Treatment of Psoriasis"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-888X","authenticated-orcid":false,"given":"Zhifeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houli","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"10556_CR1","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1111\/bjd.15610","volume":"177","author":"CEM Griffiths","year":"2017","unstructured":"Griffiths, C. E. M., van der Walt, J. M., Ashcroft, D. M., Flohr, C., Naldi, L., Nijsten, T., & Augustin, M. (2017). The global state of psoriasis disease epidemiology: A workshop report. The British Journal of Dermatology, 177, e4\u2013e7.","journal-title":"The British Journal of Dermatology"},{"key":"10556_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.abd.2021.10.002","volume":"97","author":"PP Naik","year":"2022","unstructured":"Naik, P. P. (2022). Stem cell therapy as a potential treatment option for psoriasis. Anais Brasileiros de Dermatologia, 97, 471\u20134773.","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10556_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Chen, Y., Cui, L., Shi, Y., & Guo, C. (2022). Advances in the pathogenesis of psoriasis: From keratinocyte perspective. Cell Death & Disease, 13, 81.","journal-title":"Cell Death & Disease"},{"key":"10556_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W., & Read, C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA, 323, 1945\u20131960.","journal-title":"JAMA"},{"key":"10556_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","volume":"131","author":"A Chiricozzi","year":"2011","unstructured":"Chiricozzi, A., Guttman-Yassky, E., Su\u00e1rez-Fari\u00f1as, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011). Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. The Journal of Investigative Dermatology, 131, 677\u2013687.","journal-title":"The Journal of Investigative Dermatology"},{"key":"10556_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20100163","volume":"120","author":"G Monteleone","year":"2011","unstructured":"Monteleone, G., Pallone, F., MacDonald, T. T., Chimenti, S., & Costanzo, A. (2011). Psoriasis: From pathogenesis to novel therapeutic approaches. Clinical Science (London England: 1979), 120, 1\u201311.","journal-title":"Clinical Science (London England: 1979)"},{"key":"10556_CR7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., Bowman, E. P., & Krueger, J. G. (2008). Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. The Journal of Investigative Dermatology, 128, 1207\u20131211.","journal-title":"The Journal of Investigative Dermatology"},{"key":"10556_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clim.2012.12.004","volume":"146","author":"ME Ariza","year":"2013","unstructured":"Ariza, M. E., Williams, M. V., & Wong, H. K. (2013). Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application. Clinical Immunology (Orlando Fla), 146, 131\u2013139.","journal-title":"Clinical Immunology (Orlando Fla)"},{"key":"10556_CR9","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012). Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. The New England Journal of Medicine, 366, 1190\u20131199.","journal-title":"The New England Journal of Medicine"},{"key":"10556_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/bjd.12110","volume":"168","author":"KA Papp","year":"2013","unstructured":"Papp, K. A., Langley, R. G., Sigurgeirsson, B., Abe, M., Baker, D. R., Konno, P., Haemmerle, S., Thurston, H. J., Papavassilis, C., & Richards, H. B. (2013). Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study. The British Journal of Dermatology, 168, 412\u2013421.","journal-title":"The British Journal of Dermatology"},{"key":"10556_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3899\/jrheum.200124","volume":"96","author":"LC Coates","year":"2020","unstructured":"Coates, L. C., Merola, J. F., Grieb, S. M., Mease, P. J., & Duffin, C. (2020). Methotrexate in psoriasis and psoriatic arthritis. The Journal of Rheumatology Supplement, 96, 31\u201335.","journal-title":"The Journal of Rheumatology Supplement"},{"issue":"Suppl 1","key":"10556_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000247285","volume":"187","author":"N Mozzanica","year":"1993","unstructured":"Mozzanica, N., Pigatto, P. D., & Finzi, A. F. (1993). Cyclosporin in psoriasis: Pathophysiology and experimental data. Dermatology (Basel Switzerland), 187(Suppl 1), 3\u20137.","journal-title":"Dermatology (Basel Switzerland)"},{"key":"10556_CR13","first-page":"1","volume":"20","author":"M Gooderham","year":"2015","unstructured":"Gooderham, M., Posso-De Los Rios, C. J., Rubio-Gomez, G. A., & Papp, K. (2015). Interleukin-17 (IL-17) inhibitors in the treatment of plaque psoriasis: A review. Skin Therapy Letter, 20, 1\u20135.","journal-title":"Skin Therapy Letter"},{"key":"10556_CR14","first-page":"1","volume":"12","author":"A Al-Janabi","year":"2022","unstructured":"Al-Janabi, A., & Yiu, Z. Z. N. (2022). Biologics in psoriasis: Updated perspectives on long-term safety and risk management. Psoriasis (Auckland N Z), 12, 1\u201314.","journal-title":"Psoriasis (Auckland N Z)"},{"key":"10556_CR15","doi-asserted-by":"crossref","unstructured":"Chen, M., Peng, J., Xie, Q., Xiao, N., Su, X., Mei, H., Lu, Y., Zhou, J., Dai, Y., Wang, S., Li, C., Lin, G., & Cheng, L. (2019). Mesenchymal stem cells alleviate moderate-to-severe psoriasis by reducing the production of type I interferon (IFN-I) by plasmacytoid dendritic cells (pDCs). Stem Cells International, 2019, 6961052.","DOI":"10.1155\/2019\/6961052"},{"key":"10556_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.21037\/atm-22-4","volume":"10","author":"Y Lin","year":"2022","unstructured":"Lin, Y., Wang, H., Jiang, C., Chen, C., Shen, D., Xie, F., Zhang, H., Yang, J., & Wang, H. (2022). Effects of different concentrations of human umbilical cord mesenchymal stem cells to ameliorate psoriasis-like skin lesions in BALB\/c mice. Annals of Translational Medicine, 10, 86.","journal-title":"Annals of Translational Medicine"},{"key":"10556_CR17","doi-asserted-by":"publisher","first-page":"6798","DOI":"10.12998\/wjcc.v9.i23.6798","volume":"9","author":"H Ahn","year":"2021","unstructured":"Ahn, H., Lee, S. Y., Jung, W. J., Pi, J., & Lee, K. H. (2021). Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report. World Journal of Clinical Cases, 9, 6798\u20136803.","journal-title":"World Journal of Clinical Cases"},{"key":"10556_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00441-022-03616-x","volume":"388","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Hu, Y., Zhou, X., Zhao, Z., Yu, Q., Chen, Z., Wang, Y., Xu, P., Yu, Z., Guo, C., Zhang, X., & Shi, Y. (2022). Human umbilical cord-derived mesenchymal stem cells ameliorate psoriasis-like dermatitis by suppressing IL-17-producing \u03b3\u03b4 T cells. Cell and Tissue Research, 388, 549\u2013563.","journal-title":"Cell and Tissue Research"},{"key":"10556_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jcyt.2016.03.295","volume":"18","author":"EJ Woods","year":"2016","unstructured":"Woods, E. J., Thirumala, S., Badhe-Buchanan, S. S., Clarke, D., & Mathew, A. J. (2016). Off the shelf cellular therapeutics: Factors to consider during cryopreservation and storage of human cells for clinical use. Cytotherapy, 18, 697\u201371120.","journal-title":"Cytotherapy"},{"key":"10556_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cryobiol.2015.07.003","volume":"71","author":"LA Marquez-Curtis","year":"2015","unstructured":"Marquez-Curtis, L. A., Janowska-Wieczorek, A., McGann, L. E., & Elliott, J. A. (2015). Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects. Cryobiology, 71, 181\u2013197.","journal-title":"Cryobiology"},{"key":"10556_CR21","doi-asserted-by":"publisher","first-page":"e0211382","DOI":"10.1371\/journal.pone.0211382","volume":"14","author":"Y M\u00fcllers","year":"2019","unstructured":"M\u00fcllers, Y., Meiser, I., Stracke, F., Riemann, I., Lautenschl\u00e4ger, F., Neubauer, J. C., & Zimmermann, H. (2019). Quantitative analysis of F-actin alterations in adherent human mesenchymal stem cells: Influence of slow-freezing and vitrification-based cryopreservation. PLoS One, 14, e0211382.","journal-title":"PLoS One"},{"key":"10556_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s13287-020-02054-2","volume":"11","author":"S Bahsoun","year":"2020","unstructured":"Bahsoun, S., Coopman, K., & Akam, E. C. (2020). Quantitative assessment of the impact of cryopreservation on human bone marrow-derived mesenchymal stem cells: Up to 24\u00a0h post-thaw and beyond. Stem Cell Research & Therapy, 11, 540.","journal-title":"Stem Cell Research & Therapy"},{"key":"10556_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12014-020-09279-6","volume":"17","author":"X Fu","year":"2020","unstructured":"Fu, X., Xu, B., Jiang, J., Du, X., Yu, X., Yan, Y., Li, S., Inglis, B. M., Ma, H., Wang, H., Pei, X., & Si, W. (2020). Effects of cryopreservation and long-term culture on biological characteristics and proteomic profiles of human umbilical cord-derived mesenchymal stem cells. Clinical Proteomics, 17, 15.","journal-title":"Clinical Proteomics"},{"key":"10556_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s12015-021-10320-w","volume":"18","author":"Z Wang","year":"2022","unstructured":"Wang, Z., Li, H., Fang, J., Wang, X., Dai, S., Cao, W., Guo, Y., Li, Z., & Zhu, H. (2022). Comparative analysis of the therapeutic effects of amniotic membrane and umbilical cord derived mesenchymal stem cells for the treatment of type 2 diabetes. Stem Cell Reviews and Reports, 18, 1193\u20131206.","journal-title":"Stem Cell Reviews and Reports"},{"key":"10556_CR25","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1038\/jid.2009.153","volume":"129","author":"YH Cai","year":"2009","unstructured":"Cai, Y. H., Lu, Z. Y., Shi, R. F., Xue, F., Chen, X. Y., Pan, M., Yuan, W. R., Xu, H., Li, W. P., & Zheng, J. (2009). Enhanced proliferation and activation of peripheral blood mononuclear cells in patients with psoriasis vulgaris mediated by streptococcal antigen with bacterial DNA. The Journal of Investigative Dermatology, 129, 2653\u20132660.","journal-title":"The Journal of Investigative Dermatology"},{"key":"10556_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","volume":"80","author":"SB Kaushik","year":"2019","unstructured":"Kaushik, S. B., & Lebwohl, M. G. (2019). Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents. Journal of the American Academy of Dermatology, 80, 27\u201340.","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10556_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.stemcr.2014.05.003","volume":"3","author":"R Chinnadurai","year":"2014","unstructured":"Chinnadurai, R., Garcia, M. A., Sakurai, Y., Lam, W. A., Kirk, A. D., Galipeau, J., & Copland, I. B. (2014). Actin cytoskeletal disruption following cryopreservation alters the biodistribution of human mesenchymal stromal cells in vivo. Stem Cell Reports, 3, 60\u201372.","journal-title":"Stem Cell Reports"},{"key":"10556_CR28","doi-asserted-by":"publisher","first-page":"8162","DOI":"10.1038\/s41598-018-26546-7","volume":"8","author":"S Shaik","year":"2018","unstructured":"Shaik, S., Wu, X., Gimble, J., & Devireddy, R. (2018). Effects of decade long freezing storage on adipose derived stem cells functionality. Scientific Reports, 8, 8162.","journal-title":"Scientific Reports"},{"key":"10556_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10561-021-09973-1","volume":"23","author":"M Zhang","year":"2022","unstructured":"Zhang, M., Zhao, Y., Wang, L., Zheng, Y., Yu, H., Dong, X., He, W., Yin, Z., & Wang, Z. (2022). Study of the biological characteristics of human umbilical cord mesenchymal stem cells after long-time cryopreservation. Cell and Tissue Banking, 23, 739\u2013752.","journal-title":"Cell and Tissue Banking"},{"key":"10556_CR30","doi-asserted-by":"publisher","first-page":"12842","DOI":"10.3390\/ijms222312842","volume":"22","author":"S Horie","year":"2021","unstructured":"Horie, S., Gonzalez, H., Brady, J., Devaney, J., Scully, M., O\u2019Toole, D., & Laffey, J. G. (2021). Fresh and cryopreserved human umbilical-cord-derived mesenchymal stromal cells attenuate injury and enhance resolution and repair following ventilation-induced lung injury. International Journal of Molecular Sciences, 22, 12842.","journal-title":"International Journal of Molecular Sciences"},{"key":"10556_CR31","doi-asserted-by":"publisher","first-page":"18078","DOI":"10.1038\/s41598-019-54462-x","volume":"9","author":"Y Tan","year":"2019","unstructured":"Tan, Y., Salkhordeh, M., Wang, J. P., McRae, A., Souza-Moreira, L., McIntyre, L., Stewart, D. J., & Mei, S. H. J. (2019). Thawed mesenchymal stem cell product shows comparable immunomodulatory potency to cultured cells in vitro and in polymicrobial septic animals. Scientific Reports, 9, 18078.","journal-title":"Scientific Reports"},{"key":"10556_CR32","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez, M. A., Gonzalez-Rey, E., Rico, L., B\u00fcscher, D., & Delgado, M. (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology, 136, 978\u2013989.","journal-title":"Gastroenterology"},{"key":"10556_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/art.39477","volume":"68","author":"AT Maria","year":"2016","unstructured":"Maria, A. T., Toupet, K., Bony, C., Pirot, N., Vozenin, M. C., Petit, B., Roger, P., Batteux, F., Le Quellec, A., Jorgensen, C., No\u00ebl, D., & Guilpain, P. (2016). Antifibrotic, antioxidant, and immunomodulatory effects of mesenchymal stem cells in hocl-induced systemic sclerosis. Arthritis & Rhematology, 68, 1013\u20131025.","journal-title":"Arthritis & Rhematology"},{"key":"10556_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13287-017-0540-3","volume":"8","author":"AM Robinson","year":"2017","unstructured":"Robinson, A. M., Rahman, A. A., Miller, S., Stavely, R., Sakkal, S., & Nurgali, K. (2017). The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis. Stem Cell Research & Therapy, 8, 87.","journal-title":"Stem Cell Research & Therapy"},{"key":"10556_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt, A., & Chiricozzi, A. (2018). The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clinical Reviews in Allergy & Immunology, 55, 379\u2013390.","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"10556_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cyto.2018.08.025","volume":"111","author":"K Furue","year":"2018","unstructured":"Furue, K., Ito, T., & Furue, M. (2018). Differential efficacy of biologic treatments targeting the TNF-\u03b1\/IL-23\/IL-17 axis in psoriasis and psoriatic arthritis. Cytokine, 111, 182\u2013188.","journal-title":"Cytokine"},{"key":"10556_CR37","first-page":"493","volume":"14","author":"Y Shi","year":"2018","unstructured":"Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018). Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nature Reviews, 14, 493\u2013507.","journal-title":"Nature Reviews"},{"key":"10556_CR38","doi-asserted-by":"crossref","unstructured":"Schrepfer, S., Deuse, T., Reichenspurner, H., Fischbein, M. P., Robbins, R. C., & Pelletier, M. P. (2006). Stem cell transplantation: the lung barrier. Transplantation Proceedings, 2, 573\u2013576.","DOI":"10.1016\/j.transproceed.2006.12.019"},{"key":"10556_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13287-018-0979-x","volume":"1","author":"J Fan","year":"2018","unstructured":"Fan, J., Tang, X., Wang, Q., Zhang, Z., Wu, S., Li, W., Liu, S., Yao, G., Chen, H., & Sun, L. (2018). Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9. Stem Cell Research & Therapy, 1, 237.","journal-title":"Stem Cell Research & Therapy"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-023-10556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-023-10556-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-023-10556-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T12:22:43Z","timestamp":1690806163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-023-10556-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10556"],"URL":"https:\/\/doi.org\/10.1007\/s12015-023-10556-8","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"8 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The number of animals used in the research as well as experimental procedures had been reviewed and approved by the Institutional Animal Care and Use Committee (IACUC No. ACU20-1719). Mouse care and experiments were performed following the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The clinical study was approved by the Stem Cell Research Ethics Committee of Shanghai Tenth People\u2019s Hospital of Tongji University, China (approval No. SC-2020-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Consent for publication was obtained from every participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests. The authors from Sinoneural Cell Engineering Group Holdings Co., Ltd. helped in the preparation of the MSCs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}